Johnson & Johnson unveils ‘India Detects to Defeat’ initiative to urge for early lung cancer detection & testing

New Delhi: Johnson & Johnson (J&J) India announced the launch of its nationwide campaign, India Detects to Defeat, highlighting the critical role of early detection and testing in improving lung cancer outcomes. The first phase of this initiative features a collaboration with Amar Chitra Katha, one of India’s most beloved storytellers, to create an engaging, illustrated booklet that simplifies complex medical information.

This resource is designed to assist patients, and their families in better understanding the risks, symptoms, and importance of early diagnosis for lung cancer. Available in both print and digital formats, the booklet can be accessed at select healthcare provider (HCP) clinics or online via the J&J India website.

According to the Indian Council of Medical Research (ICMR), lung cancer cases in India are projected to rise dramatically, with a seven-fold increase anticipated by 2025. In 2022 alone, approximately 81,000 cases of lung cancer were reported, along with 75,000 deaths, making it one of the leading causes of cancer-related mortality in the country.

India Detects to Defeat, primarily focuses on raising awareness about Non-Small Cell Lung Cancer (NSCLC), which accounts for 85% of all lung cancer cases globally as per the Lancet Regional Health – Southeast Asia 2024. This type of cancer is often associated with genetic mutations, epidermal growth factor receptor (EGFR) gene, which can drive uncontrolled cell growth and division.

Awareness is the first step toward early detection, timely intervention, and improved outcomes in lung cancer care. Through this initiative, Johnson & Johnson aims to bridge the awareness gap by presenting critical information in an accessible and easy-to-understand format.

Heading the Johnson & Johnson Innovative Medicine India & South Asia operations, Pushkar Kulkarni said, “Partnering with Amar Chitra Katha in the first phase of the ‘India Detects to Defeat’ campaign, lets us spread lung cancer awareness in a way that’s both accessible and memorable. Through storytelling, we simplify complex information, reaching families across India and empowering them to recognize early signs and seek timely care. This booklet is our call to action: know the signs, seek early diagnosis, consult your physician for guidance and take a stand against this silent killer. Together, we can make a real impact on early detection and save lives.”

Gayathri Chandrasekhar, Editor-in-Chief, Amar Chitra Katha (Tinkle) added, “At Amar Chitra Katha, we believe in the power of stories to inspire, educate, and bring positive change. This partnership helps us reach a broader audience, delivering a complex health message simply. Through relatable narratives, we hope to spark conversations around lung health and early detection, empowering families to make informed health decisions.”

As per the World Health Organization, lung cancer is the leading cause of cancer-related deaths worldwide, accounting for the highest mortality rates among both men and women. This disease is often diagnosed at advanced stages when treatment options are limited. Screening high risk individuals has the potential to allow early detection and to improve survival rates.